ITIH4, as an inflammation biomarker, mainly increases in bacterial bloodstream infection

Cytokine. 2021 Feb:138:155377. doi: 10.1016/j.cyto.2020.155377. Epub 2020 Dec 18.

Abstract

Bloodstream infection (BSI) is usually accompanied with the changes of varieties of inflammation proteins. In our previous study, we identified that inter-α-trypsin inhibitor heavy chain H4 (ITIH4) was highly expressed in the infection arms than the normal control arm. However, the correlated verification and mechanism remain obscure. Escherichia coli infected mice model and clinical serum samples were used to validate the concentration of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), as well as ITIH4, in ELISA method. Cytokines (IL-6, TNF-α, IL-10 and lipopolysaccharide (LPS)) were used to stimulate the HepG2 cell model to explore which cytokines influence the expression of ITIH4. JAK/STAT inhibitor was treated before IL-6 and LPS stimulation. Westernblot, as well as real-time PCR were performed to detect the expression of ITIH4 in liver tissue from protein and transcription levels. Immunohistochemistry analysis was used to observe the expression of ITIH4 in mice liver tissue. In mice model, IL-6, TNF-α, as well as IL-10 increased in the infection arms than the normal control arm. ITIH4 in serum and liver tissue of mice model increased from 1 h to 128 h, which were remarkably different from that of the normal control arm. Besides, ITIH4 increased in the bacterial infection arm greatly than the fungemia arm, mycoplasma pneumoniae (MP) arm and febrile arm in clinical serum samples. Furthermore, using the HepG2 cell line, we demonstrated that ITIH4 was up-regulated at both protein and mRNA levels upon dose- and time- response treatments with IL-6, as well as LPS. Moreover, IL-6 or LPS mediated induction of ITIH4 expression could be significantly decreased by treatment with an JAK/STAT inhibitor in protein or mRNA level. No changes were observed after TNF-α or IL-10 stimulation. ITIH4 might be a critical inflammatory biomarker which correlated with the development of BSI, especially with bacterial bloodstream infection. It is expected that this study would provide some insights into potential functional mechanisms underlying BSI.

Keywords: Bacterial bloodstream infection; Cytokines; Fungemia; ITIH4; New biomarker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Biomarkers / blood*
  • Child
  • Child, Preschool
  • Disease Models, Animal
  • Escherichia coli / metabolism
  • Escherichia coli Infections
  • Female
  • Hep G2 Cells
  • Hepatocytes / metabolism
  • Humans
  • Inflammation / blood*
  • Interleukin-10 / blood
  • Interleukin-6 / blood
  • Janus Kinases / metabolism
  • Lipopolysaccharides / metabolism
  • Male
  • Mice
  • Mice, Inbred ICR
  • Middle Aged
  • Proteinase Inhibitory Proteins, Secretory / blood*
  • RNA, Messenger / metabolism
  • STAT Transcription Factors / metabolism
  • Sepsis / blood*
  • Sepsis / diagnosis
  • Tumor Necrosis Factor-alpha / blood
  • Young Adult

Substances

  • Biomarkers
  • IL10 protein, human
  • IL10 protein, mouse
  • IL6 protein, human
  • ITIH4 protein, human
  • Interleukin-6
  • Itih4 protein, mouse
  • Lipopolysaccharides
  • Proteinase Inhibitory Proteins, Secretory
  • RNA, Messenger
  • STAT Transcription Factors
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • Interleukin-10
  • Janus Kinases